1. Home
  2. GABC vs INBX Comparison

GABC vs INBX Comparison

Compare GABC & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

HOLD

Current Price

$49.77

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$106.80

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GABC
INBX
Founded
1910
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
GABC
INBX
Price
$49.77
$106.80
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$47.67
$150.00
AVG Volume (30 Days)
94.6K
328.0K
Earning Date
04-27-2026
05-15-2026
Dividend Yield
2.88%
N/A
EPS Growth
8.13
N/A
EPS
1.90
N/A
Revenue
$487,401,000.00
$1,300,000.00
Revenue This Year
$16.78
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$26.18
N/A
Revenue Growth
37.80
550.00
52 Week Low
$37.19
$26.19
52 Week High
$52.23
$155.29

Technical Indicators

Market Signals
Indicator
GABC
INBX
Relative Strength Index (RSI) 52.41 51.72
Support Level $48.85 $70.23
Resistance Level $51.97 $131.01
Average True Range (ATR) 0.80 9.82
MACD -0.05 -2.00
Stochastic Oscillator 69.15 44.50

Price Performance

Historical Comparison
GABC
INBX

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: